Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer.
Cancer Treat Rev. 2020 Jun;86:102021. doi: 10.1016/j.ctrv.2020.102021. Epub 2020 Apr 10.
Cancer Treat Rev. 2020.
PMID: 32311593
Free PMC article.
Review.